EP3453402
REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY
:
EP einkaleyfi: Þýðing ekki lögð inn:
12.1.2013:
21.7.2021:
18183272.6
:
11.1.2033
:
REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY
12.1.2013
21.7.2021
:
Bioverativ Therapeutics Inc.:
225 Second Avenue, Waltham MA 02451, US
:
Puget Sound Blood Center:
921 Terry Avenue, Seattle, Washington 98104-1256, US
:
JIANG, Haiyan:
Belmont, MA Massachusetts 02478, US
:
LIU, Tongyao:
Lexington, MA Massachusetts 02421, US
:
KRISHNAMOORTHY, Sriram:
Acton, MA Massachusetts 01720, US
:
JOSEPHSON, Neil:
Seattle, WA Washington 98104-1256, US
:
GLENN, Pierce:
Cambridge, MA Massachusetts 02142, US
:
201261586103 P:
12.1.2012:
US
:
201261668961 P:
6.7.2012:
US
:
A61K 38/21, A61K 38/37, A61K 39/00, A61K 47/68, C12Q 1/68, C07K 14/755, C12Q 1/6883, A61P 37/06